Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS

Edoardo Elia1, Francesco Bruno2, Gabriele Crimi3

  • 1Division of Cardiology, "Città della Salute e della Scienza di Torino" Hospital, Department of Medical Sciences, University of Turin, Turin 10126, Italy; DICATOV-Cardiothoracic and Vascular Department, San Martino Hospital, IRCCS for Oncology and Neurosciences, Genoa, Italy.

PubMed

Insights

Women face a higher risk of heart failure (HF) after acute coronary syndrome (ACS). Female sex independently predicts HF hospitalization and cardiovascular death, highlighting gender as a crucial factor in post-ACS outcomes.

Area of Science:

  • Cardiology
  • Clinical Research
  • Sex Differences in Medicine

Background:

  • The impact of gender on cardiac remodeling following acute coronary syndrome (ACS) and subsequent heart failure (HF) development requires further investigation.
  • Understanding sex-specific differences in cardiovascular disease progression is crucial for personalized treatment strategies.

Purpose of the Study:

  • To investigate the influence of gender on heart remodeling and the risk of heart failure (HF) after acute coronary syndrome (ACS).
  • To identify gender-specific predictors of adverse cardiovascular outcomes in patients treated for ACS.

Main Methods:

  • The study utilized the CORALYS registry, a multicenter, retrospective, observational cohort of patients admitted for ACS and treated with percutaneous coronary intervention.
  • Primary endpoint was HF hospitalization; secondary endpoints included all-cause mortality and a composite of HF hospitalization and cardiovascular mortality.
  • Multivariable analysis was employed to identify independent predictors of HF in both men and women.

Main Results:

  • Out of 14,699 patients, 31% were women, who were older and had more comorbidities like hypertension and diabetes compared to men.
  • Women exhibited a higher incidence of primary and secondary endpoints, with female sex being an independent predictor of HF hospitalization and cardiovascular death/HF hospitalization.
  • While shared predictors of HF included diabetes and chronic kidney disease, specific predictors differed: COPD and diuretics for men, and prior MI and renin-angiotensin system inhibitors for women.

Conclusions:

  • Women are at an elevated risk for developing heart failure after acute coronary syndrome.
  • Gender acts as a significant outcome modifier, influencing the relationship between various clinical factors and the risk of heart failure post-ACS.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436